Viking Therapeutics Inc (VKTX) Stock Analysis

Viking Therapeutics Inc (VKTX) is a publicly traded company in the HEALTHCARE sector. It trades at $29.29, carries a market capitalization of $3.63B. This page summarizes the public market data, fundamentals, and frequently asked questions for VKTX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Viking Therapeutics Inc currently has a Bullish sentiment score of 0.31.

About Viking Therapeutics Inc

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, specializing in the development of innovative therapies targeting metabolic and endocrine disorders. The company's robust pipeline includes novel drug candidates designed to address significant unmet medical needs, with a focus on conditions such as obesity and liver disease. Leveraging its proprietary drug development platforms and expertise in metabolic pathways, Viking aims to enhance pa...

GNG Research Analysis

GNG Research scores Viking Therapeutics Inc (VKTX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for VKTX.

Frequently Asked Questions

Does VKTX pay dividends?

Viking Therapeutics Inc (VKTX) does not currently pay a regular dividend.

What is VKTX's market cap?

Viking Therapeutics Inc (VKTX) has a market capitalization of $3.63B with a current stock price of $29.29.